RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients (Q35010521)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients |
scientific article |
Statements
1 reference
RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients (English)
1 reference
Peter J Quesenberry
1 reference
Sam Cross-Knorr
1 reference
Shaolei Lu
1 reference
Kimberly Perez
1 reference
Sara Guevara
1 reference
Kate Brilliant
1 reference
Claudio Pisano
1 reference
Murray B Resnick
1 reference
Devasis Chatterjee
1 reference
8 October 2013
1 reference
1 reference
13
1 reference
463
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference